**Multiple IPOs are scheduled or in advanced stages for October through December 2026, driving near-certain market-implied odds of at least one completion before year-end.** As of October 8, 2026, 251 U.S. IPOs have already priced year-to-date, including recent listings such as Southport Acquisition Corp. II and Accelevation Holdings Corp., with immediate upcoming deals like TRex Bio (TRXB) set for October 9 at a $14–16 range. High-profile candidates including Anthropic (targeting mid-November at potentially multi-trillion valuation) and others with confidential or amended filings maintain active pipelines amid elevated equity valuations and risk appetite for growth and AI names. Broader 2026 issuance has already surpassed prior-year totals in count, supported by stable monetary policy and equity market levels, though exact timing for mega-deals remains subject to final roadshow execution and regulatory clearance.